Test Code GDF15 Growth Differentiation Factor 15, Plasma
Useful For
A circulating biomarker in myopathy-related mitochondrial disease as well as other conditions
Investigation of patients suspected of having a mitochondrial myopathy
This assay is not suitable for carrier detection.
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
Growth Differentiation Factor 15, PClinical System Name: Growth Differentiation Factor 15 (GDF15)
Specimen Type
PlasmaSpecimen Required
Collection Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Green top (sodium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Draw blood and centrifuge immediately.
2. Aliquot plasma into plastic vial.
3. Do not expose specimen to heat or direct sunlight.
Collect at least 1 mL whole blood in a lavender tube, spin and aliquot 0.5 mL plasma into an amber vial. Place in refrigerated send outs box.
Specimen Minimum Volume
0.2 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Plasma | Refrigerated (preferred) | 90 days |
Frozen | 90 days | |
Ambient | 28 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
3 months* and older: ≤750 pg/Ml
*This test is not recommended for infants younger than 3 months of age due to the high levels of growth differentiation factor 15 contributed from the placenta during pregnancy.
Method Description
Growth differentiation factor 15 (GDF15) enzyme-linked immunosorbent assay is a quantitative sandwich enzyme immunoassay technique. Specimen is incubated in wells that have been coated with anti-GDF15 antibody. After incubation and washing, the wells are incubated with an enzyme-linked polyclonal antibody specific for human GDF15. After a second incubation and washing step, the wells are incubated with a substrate solution producing a blue color. A stop solution is added turning the blue color to yellow, which is then read on a microplate reader. The resulting absorbance is directly proportional to the level of GDF15 in the specimen.(Unpublished Mayo method)
Day(s) Performed
Wednesday, Friday
TAT: 10 - 17 days
Report Available
2 to 6 daysPerforming Laboratory

Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83520
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
GDF15 | Growth Differentiation Factor 15, P | 92665-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
64637 | Growth Differentiation Factor 15, P | 92665-9 |
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
Special Instructions
Testing Algorithm
For information see Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm